ONL | INL | GCL | |
---|---|---|---|
% | |||
Control | 953 ± 43 | 259 ± 9 | 37 ± 4 |
Ischemia | 590 ± 15 (38)a | 119 ± 6 (54)a | 18 ± 2 (51)a |
Ischemia/reperfusion | 574 ± 30 (40)a | 96 ± 13 (63)a | 16 ± 1 (58)a |
FrPbAII/ischemia | 748 ± 28 (27)b | 186 ± 10 (57)b | 27 ± 2 (50)b |
FrPbAII/ischemia/reperfusion | 688 ± 23 (20)c | 174 ± 9 (81)c | 23 ± 1 (44)c |
↵ a Percentage of cell losses compared with control retinas in nonischemic conditions
↵ b Percentage of decrease in cell losses with FrPbAII treatment compared with ischemic conditions (protection percentage)
↵ c Percentage of decrease in cell losses with FrPbAII treatment compared with ischemic/reperfusion conditions (protection percentage)